Global IV Solution Bags 麻豆原创 Size, Competition and Demand Analysis Report #InsightsIV solution bags, also known as IV bags or IV fluid bags, are medical devices used to administer fluids, medications, and nutrients directly into a patient's bloodstream through an intravenous (IV) catheter. They are commonly used in hospitals, clinics, and other medical facilities. IV bags are typically made of flexible plastic and come in different sizes, ranging from 50 mL to 1,000 mL or more. The most common sizes are 250 mL and 500 mL. The bags are usually filled with sterile saline solution, a salt and water solution that closely mimics human blood's electrolyte balance. Other IV solutions can also be used, such as dextrose solution, which contains glucose, or lactated Ringer's solution, which contains various electrolytes. Report Forecast The global IV Solution Bags market was valued at US$ xx million in 2022 and is anticipated to reach US$ xx million by 2029, witnessing a...Read more | USD 2,900.00 |
Global Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product , Dosage Form , Disease , Setting , and Region: Trend Forecast and Growth OpportunityGlobal ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 80 tables and 89 figures, this 196-page report 鈥淕lobal Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, 麻豆原创care Settings, ASCs, Others), and Region: Trend Forecast and Growth Opportunity鈥� is...Read more | USD 3,580.00 |
North America Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product , Dosage Form , Disease , Setting , and Country: Trend Forecast and Growth OpportunityNorth America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 20 tables and 53 figures, this 116-page report 鈥淣orth America Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, 麻豆原创care Settings, ASCs, Others), and Country: Trend...Read more | USD 2,980.00 |
Europe Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product , Dosage Form , Disease , Setting , and Country: Trend Forecast and Growth OpportunityEurope ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 30 tables and 57 figures, this 127-page report 鈥淓urope Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, 麻豆原创care Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity...Read more | USD 2,980.00 |
Asia Pacific Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product , Dosage Form , Disease , Setting , and Country: Trend Forecast and Growth OpportunityAsia Pacific ophthalmic drug delivery system market will grow by 8.9% annually with a total addressable market cap of $56,139.1 million over 2022-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 27 tables and 56 figures, this 127-page report 鈥淎sia Pacific Ophthalmic Drug Delivery System 麻豆原创 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, 麻豆原创care Settings, ASCs, Others), and Country: Trend...Read more | USD 2,980.00 |
0 items USD 0.00
Printer version
Send by email
